End-payors of Restasis seek final approval of settlement with Allergan in US antitrust case
MLex Summary: End-payors of Restasis asked a US judge to grant final approval to their $30 million settlement with Allergan to resolve allegations that it illegally blocked generic competition for the...To view the full article, register now.
Already a subscriber? Click here to view full article